
Number of publications published per year by Fishman, Sarah. (Source : PubMed)

Distribution of publications types for Fishman, Sarah. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
Syndecan 1 (CD138) serum levels: a novel biomarker in predicting liver fibrosis stage in patients with hepatitis C.
Liver Int.
2009;29;2

Humanin: a novel central regulator of peripheral insulin action.
PLoS ONE
2009;4;7
Developing a novel model system to target insulin-reactive CD8 T cells.
Ann. N. Y. Acad. Sci.
2008;1150

The burden of unintentional injuries among the under-five population in South Asia.
Acta Paediatr.
2008;97;3

Accretion of visceral fat and hepatic insulin resistance in pregnant rats.
Am. J. Physiol. Endocrinol. Metab.
2008;294;2
Transport and Anderson localization in disordered two-dimensional photonic lattices.
Nature
2007;446;7131

Central and opposing effects of IGF-I and IGF-binding protein-3 on systemic insulin action.
Diabetes
2006;55;10

Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease.
Gastroenterology
2006;131;2
Scaling and universality of the complexity of analog computation.
Chaos
2006;16;2
Role of CYP2D6 polymorphism in predicting liver fibrosis progression rate in Caucasian patients with chronic hepatitis C.
Liver Int.
2006;26;3
[ See timeline ] [ See all publications ]
means that Fishman, Sarah has 19 papers cited a least 19 times - methodology
IBD Service, Department of Gastroenterology and Liver Diseases, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.